4,5,6,7-Tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acids (spinacines)

New derivatives of the naturally occurring amino acid 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid (spinacine) are reported. These include amide, ester, 5-alkyl and acyl, and regiospecific N^im-alkyl and aralkyl derivatives. Synthesis via the Pictet-Spengler reaction on N^im-substituted histidines is described. Cyclic hydantoin derivatives of spinacines are included.     

Synthesis of 4,7-dihydro-4-oxoisoxazolo[5,4-b]pyridine-5-carboxylic acid derivatives as potential antimicrobial agents

Synthetic approaches to 3-substituted-7-ethyl-4,7-dihydro-4-oxoisoxazolo[5,4-b]pyridine-5-carboxylic acid derivatives from 3-substituted-5-aminoisoxazoles are reported.     

Hydroxyiminoisoquinolin-3(2H)-ones. 9. Synthesis of some oxazolo[5,4-c]-, thiazolo[5,4-c]- and 2,3-dihydro-1H-[1,4]oxazino[2,3-c]isoquinolines

4-Acetylamino-1-phenyl-1,4-dihydro-3(2H)-isoquinolinones and 4-amino-1-phenylisoquinolin-3-ol, prepared from the corresponding 4-hydroxyimino compounds, were converted into new isoquinolines containing fused oxazole, thiazole and 1,4-oxazine rings.     

Synthesis of N-substituted-2-{ 4,5,6,7-tetrahydrothieno [ 3,2-c ] pyridine-5-yl } acetamides and Their Anti-platelet Aggregation Activities

以4,5,6,7-四氢噻吩并[3,2-c]毗啶盐酸盐和2-氧代-2,4,5,6,7,7a-六氢噻吩并[3,2-c]吡啶盐酸盐为起始原料,合成了9个未见文献报道的ADP受体拮抗剂——N-取代-2-14,5,6,7-四氢噻吩并[3,2-c]吡啶-5-基}乙酰胺(1a～1e,2a～2d),收率61.4％-80.3％,其结构经1H NMR和HR-MS表征.大鼠体内抗血小板聚集活性研究表明,1和2均有一定的抗血小板聚集作用,其中1d和2d的作用较强,抑制效率分别为50.0％和58.9％,且2d的抑制作用优于阳性对照药噻氯匹定.     

Synthesis of 7-ethyl-4,7-dihydro-4-oxo-2-(4-pyridinyl)thieno[2,3-b]pyridine-5-carboxylic acid

7-Ethyl-4,7-dihydro-4-oxo-2-(4-pyridinyl)thieno[2,3-b]pyridine-5-carboxylic acid ( 4 ), an analog of nalidixic acid, was synthesized in seven steps starting from commercially available 4-methylpyridine. Bacterial susceptibility to compound 4 was tested and the title compound was found to exhibit only weak antibacterial activity against a variety of pathogens including S. Aureus, E. Coli and P. Aeruginosa.     

Synthesis and Crystal Structure of Spiro[1-bromo(S)-4-(R)-hydroxy- 5-oxa-6-oxo-bicyclo[3.1.0]hexane-2,2''-(3''-diethyl-(-(S)-4''-Cl-benzyloxyphosphonyl-4''-(1R,2S,5R)-menthyloxybutyrolactone)]

The title compound, spiro[1-bromo(S)-4-(R)-hydroxy-5-oxa-6-oxo-bicyclo[3.1.0]-hxane-2,2'-(3'-diethyl-α-(S)-4'-Cl-benzyloxyphosphonyl-4'-(1R,2S,5R)-menthyloxybutyrolactone)] has been synthesized via the tandem asymmetric reaction and it crystallizes in a monoclinic system, space group P21 with a = 11.067(3), b = 12.484(2), c = 12.356(2)(A), β = 101.95°,C29H39BrC1O10P, Mr = 693.93, V= 1670.2(6) (A)3, Z= 2, Dc= 1.380 g/cm3, λ(MoKα) = 0.071073nm, μ = 1.410 mm-1, F(000) = 720, the final R = 0.0570 and wR = 0.0758 for 6190 observed reflections with I ＞ 2σ(I). The structure is characterized by the special combination of biologic phosphonyl group and one cyclopropane as well as two butyrolactones. The intermolecular hydrogen bond between O(3)-H(3A)…O(10) in the crystal lattice has been observed.     

Application of [2,3]Wittig and [3,3]Claisen rearrangements in steroid side chain synthesis. A highly stereocontrolled entry to either (22 S)- or (22 R)-hydroxy-23-carboxylic acid

An efficient approach to either (22 S)- or (22 R)-hydroxy-23-carboxylic acid side chain is described which relies on the stereochemical transmission via [2,3]Wittig or [3,3]Claisen sigmatropic rearrangement, respectively.     

3αR-苄基-1-(叔丁基)氧羰基-2-甲基-4,5,6,7-四氢-2H-吡唑并[4,3-c]吡啶-3-(3H)-酮的合成

在O-烯丙基-N-9-蒽甲基溴化辛可宁的催化下,1-苄基-3-乙氧羰基-4-哌啶酮与溴化苄经不对称苄基化反应制得(R)-1,3-二苄基-4-氧代哌啶-3-甲酸乙酯(3); 3脱除Bn保护基并经Boc保护转化为(R)-3-苄基-1-(叔丁基)氧羰基-4-氧代哌啶-3-甲酸乙酯(5); 5与甲基肼在乙醇中经环化反应合成了Capromorelin的关键中间体3αR-苄基-1-(叔丁基)氧羰基-2-甲基-4,5,6,7-四氢-2H-吡唑并[4,3-c]吡啶-3-(3H)-酮,收率70%, ee值69.1%,其结构经¹H NMR, ¹³C NMR和HR-MS（ESI）确证。     

Enantiospecific synthesis of the sugar amino acid (2S,5S)-5-(aminomethyl)-tetrahydrofuran-2-carboxylic acid

An enantiospecific synthesis of the tetrahydrofuran amino acid (2S,5S)-5-(aminomethyl)-tetrahydrofuran-2-carboxylic acid 1 is reported. The sugar enone 2-(S)-octyl 6-O-acetyl-3,4-dideoxy-α-d-glycero-hex-3-enopyranosid-2-ulose 2a, derived from galactose, was employed as a chiral precursor. The enone 2a was converted by chemical manipulation of the functional groups into the 6-azido-2-O-tosyl-3,4,6-trideoxy-d-erythro-hexono-1,5-lactone 9 as key intermediate. Methanolysis of 9 induced the opening of the lactone and the attack of the hydroxyl group at C-5 to C-2 with the displacement of the tosylate. This reaction led to the formation of the tetrahydrofuran ring of methyl (2S,5S)-5-(azidomethyl)-tetrahydrofuran-2-carboxylate 10, which was readily converted into 1. The overall yield of the sequence was 35%, and all the intermediates and the final product have been fully characterized. In addition, the preferential conformations in solution of lactone 9 and target molecule 1 have been established.